zonisamide has been researched along with Day Blindness in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zonisamide treatment was discontinued." | 1.56 | Zonisamide-induced Choroidal Effusion: A Case Report. ( Baradad Jurjo, MC; Caminal Mitjana, JM; Lillo Sopena, J; Moix Gil, E; Sanz Moreno, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baradad Jurjo, MC | 1 |
| Sanz Moreno, S | 1 |
| Moix Gil, E | 1 |
| Lillo Sopena, J | 1 |
| Caminal Mitjana, JM | 1 |
1 other study available for zonisamide and Day Blindness
| Article | Year |
|---|---|
Zonisamide-induced Choroidal Effusion: A Case Report.
Topics: Aged; Anticonvulsants; Choroidal Effusions; Female; Humans; Intraocular Pressure; Microscopy, Acoust | 2020 |